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Abstract
Aims: Parathyroid hormone-related protein (PTHrP) is involved in lung
development and surfactant production. The latter one requires a paracrine
interaction between type II alveolar cells and lipofibroblasts in which leptin
triggers PTHrP-induced effects. Whether increased plasma leptin levels, as they
occur in high fat diet, modify the expression of PTHrP remains unclear.
Furthermore, the effect of high fat diet under conditions of forced pulmonary
remodelling such as response to post myocardial infarction remains to be defined.
Materials and methods: C57 bl/6 mice were randomized to either normal diet or
high fat diet at an age of 6 weeks. Seven months later, the mice were euthanized
and the lung was removed and frozen in fluid nitrogen until use. Samples were
analyzed by real-time RT-PCR and western blot. Leptin deficient mice were used
to investigate the effect of leptin on pulmonary expression of PTHrP more directly.
A subgroup of mice with and without high fat diet underwent in vivo ischemia
(45 min) and reperfusion (4 weeks). Finally, experiments were repeated with
prolonged high-fat diet.
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Key findings: High fat diet increased plasma leptin levels by 30.4% and the
pulmonary mRNA expression of PTHrP (1,447-fold), PTH-1 receptor (4.21-fold),
and PTHrP-downstream targets ADRP (7.54-fold) and PPARγ (5.27-fold).
Pulmonary PTHrP expression was reduced in leptin deficient mice by 88%
indicating leptin dependent regulation. High fat diet further improved changes in
pulmonary adaptation caused by ischemia/reperfusion (1.48-fold increased PTH-1
receptor protein expression). These effects were lost during prolonged high fat diet.
Significance: This study established that physiological regulation of leptin plasma
levels by high fat diet affects the pulmonary PTHrP expression and of PTHrP
downstream targets. Modification of pulmonary expression of PTH-1 receptors by
high fat diet after myocardial infarction suggests that the identified interaction may
participate in the obesity paradox.
Keywords: Medicine, Physiology
1. Introduction
Parathyroid hormone-related protein (PTHrP) and its corresponding receptor,
parathyroid hormone (PTH)-1 receptor, are essential for regular foetal lung
development and are required to maintain regular lung function [22, 23]. The
PTHrP pathway participates in the regulation of type II alveolar cell proliferation,
differentiation, apoptosis, and surfactant formation [21]. Type II alveolar cells
release PTHrP that acts on adjacent lipofibroblasts via stimulation of the PTH-1
receptor-mediated cAMP pathway. This leads to an induction of the expression of
adipocyte differentiation-related protein (ADRP) and peroxisome proliferator-
activated receptor (PPAR)-γ in lipofibroblasts. Both factors improve lipid uptake,
formation of surfactants, and attenuate transdifferentiation of lipofibroblasts into
myofibroblasts [23]. Furthermore, lipofibroblasts produce leptin that then acts as a
positive feedback modulator on the expression of surfactant proteins by type II
alveolar cells. Transdifferentiation of lipofibroblasts into myofibroblasts is a major
problem in lung disease and it is also inhibited by PTHrP [23]. On the other side,
PTHrP deficiency or defect in PTH-1 receptor activation attenuate proliferation
and differentiation of type II alveolar cells and instead of alveolarization,
angiotensin II is produced that further damages the lung [21, 26, 28].
In this study we focus on the role of leptin in the regulation of pulmonary PTHrP
expression. Although leptin has been identified as a paracrine factor in the lung that
participates in PTHrP-dependent regulation of surfactants, the relationship between
obesity, plasma leptin concentrations, and the role of leptin as a paracrine factor in
pulmonary function and differentiation has to be clarified. In general, obesity is
associated with a high risk to develop lung disease and also associated with high
plasma levels of leptin [10]. Under conditions of high fat diet (HFD) leptin plasma
levels increase but it remains unclear whether this will be sufficient to affect
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pulmonary expression of PTHrP and of its downstream targets ADRP and PPARγ.
It is important to clarify this point for an understanding of the relationship between
obesity and pulmonary disease. This is specifically interesting in conditions of
pulmonary stress as it occurs after myocardial infarction.
Myocardial infarction leads to a transient reduction of cardiac pump function
thereby producing a nonsufficient support of each organ with oxygenated blood. In
this critical phase of ischemia, often also during the first period of successful
reperfusion, it is important that the remaining blood flow can efficiently be
oxygenated in the lung. However, symptoms of dyspnoea are common due to
reduced blood supply of organs including the respiratory muscles that compensate
for this imbalance of oxygen supply by forced respiration. Subsequently, lung
remodelling and pulmonary hypertension are common complications following
myocardial infarction [11, 12]. The pulmonary paradox in cardiology describes a
situation in which obese people have a higher prevalence to suffer from myocardial
infarction, but a better chance to survive such an event [2, 16]. The mechanisms
behind this paradox have not been fully understood and the interaction between fat
intake and cardioprotection remains elusive. PTHrP is a key player in pulmonary
remodelling by inhibiting the transdifferentiation of lipofibroblasts into myofibro-
blasts and supporting surfactant formation and it is regulated by leptin. Therefore,
we hypothesized that HFD will improve pulmonary remodelling. Nevertheless, it is
not yet known whether modifications of plasma leptin levels by HFD are sufficient
to modify the pulmonary expression of PTHrP. Therefore, the current study was
designed to clarify this point.
Our current understanding about the role of PTHrP for the onset of surfactant
production and release depends largely on previous studies that were performed in
models with newborn rodents [23, 24]. However, although pulmonary expression
of PTHrP is necessary to induce the formation of surfactants and inhibits
transdifferentiation of lipofibroblasts into myofibroblasts, it is less known whether
PTHrP exerts a similar role for pulmonary adaptation in adults.
In summary this study is therefore aimed to clarify the following points: Does HFD
increase plasma leptin levels significantly enough to affect pulmonary expression
of PTHrP, does myocardial infarction affect pulmonary expression of PTHrP, and
finally whether this is modified by HFD. In conclusion, this study is aimed to
clarify the role of extra-pulmonary leptin on pulmonary expression of PTHrP.
2. Materials and methods
2.1. Animals
Animal studies were approved by Research Commission on Ethics of the Hospital
Vall d’Hebron. All animal procedures conformed to EU Directive 2010/63EU and
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Recommendation 2007/526/EC regarding the protection of animals used for
experimental and other scientific purposes, enforced in Spanish law under Real
Decreto1201/2005.
C57 bl/6 mice of either sex were used at the age of 6 weeks and fed with either a
standard diet (24% kcal from protein, 18% kcal from fat and 58% kcal from
carbohydrate) obtained from Harlan Iberica (Barcelona) or a high fat diet (HFD;
20% kcal from protein, 60% kcal from fat and 20% kcal from carbohydrate)
obtained from Research Diets (New Brunswick, NJ) for 6 months. Thereafter,
animals were anesthesized (2% isofluorane), orally intubated and mechanically
ventilated (Inspira ASV, Harvard Apparatus). Mice were subjected to either a sham
procedure or 45 min myocardial ischemia via ligation of the left anterior
descending coronary artery (LAD) followed by reperfusion. Four weeks later the
mice were sacrificed and the lung was excised and quickly frozen in liquid nitrogen
until use. In additional set of experiments, C57 bl/6 mice were fed with standard
diet or HFD for 12 months before being subjected to sham or ischemia/reperfusion
protocol as described. Infarct sizes were significantly smaller in the HFD group
(16.1 ± 4.4% IS/AAR vs. 35.3 ± 8.2% IS/AAR). Infarct sizes were quantified as
follows and described before [17]: at the end of the experimental protocol, mice
were killed with an overdose of pentobarbital sodium and the hearts were perfused
for 5 min and fixed overnight with 4% paraformaldehyde and embedded in
paraffin. The heart was cross sectioned from base to apex at 200 μm intervals and
four serial 4 μm sections were obtained for each interval. Sections were stained
with Picrosirius red (Sigma-Aldrich, MO, USA), scanned and evaluated using
ImagePro Software (Image Pro-Plus, Media Cybernetics, MD, USA).
B6.V-Lepob/J mice were used as a genetic model of leptin deficiency. Mice
homozygeous for the Lepob mutation developed obesity. Mice used here were 3–5
months old.
2.2. Determination of leptin concentration
Leptin was analyzed in plasma obtained from blood samples collected before HFD
feeding and at the end of the experimental protocol using a commercial
multiplexed bead-based immunoassay (Milliplex MAP, Millipore Iberica) and
processed in a Luminex 200 instrument (Luminex Corp., Austin, TX).
2.3. Real-time RT-PCR
In order to quantify the pulmonary expression of genes of interest quantitative real-
time RT-PCR was used. Tissue samples were prepared to analyze the steady state
mRNA levels of proteins of interest according to the previously described method
[4]. Briefly, total RNA was isolated from the lungs using peqGoldTriFast (peqlab,
Biotechnology GmbH, Germany) according to the manufacturer’s protocol.
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To remove genomic DNA contamination, isolated RNA samples were treated with
1 U DNase per mg RNA (Invitrogen, Karlsruhe, Germany) for 15 min at 37 °C.
On μg of total RNA was used in 10 μl reaction to synthesize cDNA using
superscript RNaseH reverse transcriptase (200 U/μg; Invitrogen) and oligo dTs
(Roche, Mannheim, Germany) as primers. Reverse transcriptase reactions were
performed for 60 min at 37 °C. Real-time PCR was performed using the Icycler
IQ detection system (Bio-Rad, Munich, Germany) in combination with IQ SYBR
Green real-time supermix (Bio-Rad). A complete list of all primers used in this
study is given in Table 1. Data are normalized to Hypoxanthine Phosphor-
ibosyltransferase (HPRT) expression that was used as a house-keeping gene in
this study. Preliminary experiments with β2 microglobulin, which was
alternatively considered as housekeeping gene, revealed similar results but
higher variability. The relative change in expression was quantified by the 2
[-ΔΔCT] method [14].
2.4. Western Blots
Tissue samples from lungs stored at −80 °C were used as described previously and
prepared for standard SDS gel electrophoresis. Protein was extracted as described
before [4]. The extraction buffer contained (mmol/L): Mops 5, sucrose 300, EGTA
1, bovine serum albumin (0.015) and 0.01% (v/v) protease inhibitor cocktail
(Sigma, Taufkirchen, Germany). The homogenate was centrifuged at 1,000 g at
4 °C for 10 min and the supernatant was used for protein detection by Western
blotting. Protein samples were loaded on NuPAGE Bis-Tris Precast gels (10%; Life
Technology, Darmstadt, Germany) and subsequently transferred onto nitrocellu-
lose membranes. Primary antibodies directed against PTHrP, PTH-1 receptor and
α-actin (loading control) were used as described before [20].
Table 1. List of primers used in this study.
Gene Forward Reverse
PTHrP GAG ATC CAC ACA GCC GAA AT CGT CTC CAC CTT GTT GGT TT
PTH-1 receptor TTG CCT CCC TCA CCG TGG CT CGG CGC GCA GCA TAA ACG AC
ADRP CCC GCA ACC TGA CCC AGC AG CGC CTG CCA TCA CCC CCA AG
PPARγ GCC TTG CTG TGG GGA TGT TCA GCG GGA AGG ACT TTA TGT
Elastin CTG CTG CTA AGG CTG CTA AG CCA CCA ACA CCA GGA ATG
TGF-β1 GTC CTT GCC CTC TAC AAC CA GTT GGA CAA CTG CTC CAC CT
Fibronectin ACA GAG CTC AAC CTC CCT GA TGT GCT CTC CTG GTT CTC CT
β2-Microglobulin GCT ATC CAG AAA ACC CCT CAA CAT GTC TCG ATC CCA GTA GAC GGT
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2.5. Statistics
The results are expressed as means ± S.D. or box plots as indicated in the legends
to the figures. Statistical comparisons were performed by two-side ANOVA and
Student-Newman-Keuls post hoc analysis. Levene test was used to check the
normal distribution of the samples. A p value of 0.05 was considered as statistical
significant.
3. Results
3.1. Effect of high fat diet on pulmonary expression of PTHrP in
adult mice
Compared to age-matched control mice, body weight in mice fed with HFD for 6
months increased from 35.8 ± 0.9 g to 46.7 ± 0.8 g and plasma leptin levels
increased from 4.95 ± 0.83 ng/ml to 15.91 ± 2.41 ng/ml (each p < 0.001, n = 6–8).
The pulmonary expression of PTHrP mRNA increased significantly in mice fed
with HFD (Fig. 1). Similarly, the pulmonary mRNA expression of PTH-1R,
ADRP, and PPARγ increased (Fig. 1). Collectively these data are in agreement
with the hypothesis that leptin stimulates the pulmonary expression of PTHrP
under basal conditions. The relevance of this observation was confirmed in mice
with leptin deficiency due to a mutation in the leptin gene (ob-mice). Ob-mice had
also increased body weight (50.5 ± 3.8 g vs. 26.0 ± 3.2 g, n = 4, p < 0.001). In
these mice the pulmonary expression of PTHrP was significantly reduced whereas
the pulmonary expression of PTH-1R, ADRP, and PPARγ remained unchanged
(Fig. 2).
Interestingly, the effect of HFD on the pulmonary expression of mRNA PTHrP,
PTH-1R, and PTHrP downstream targets C57 bl/6 mice was lost when feeding was
further extended for another 6 months (Fig. 3). Tissue levels of PTHrP and the
[(Fig._1)TD$FIG]
Fig. 1. Pulmonary mRNA expression of PTHrP, PTH-1 receptor, ADRP, and PPARγ in seven months
old mice that were fed with either normal diet (ND, n = 12) or high fat diet (HFD, n = 7). Data are
expressed as means ± S.D. *, p < 0.05 vs. ND.
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PTH-1R protein expression were not affected by HFD at any of the two time points
(Fig. 4).
3.2. Effect of ischemia/reperfusion on PTHrP and PTH-1
receptor protein expression
In mice subjected to ischemia/reperfusion the pulmonary mRNA expression of
PTHrP increased in the group fed with normal diet four weeks after infarction
while no additive effect was observed in the HFD group (Fig. 5). The mRNA
expression of the PTH-1 receptor remained unchanged in mice undergoing
ischemia/reperfusion (Fig. 5). The pulmonary mRNA expression of two PTHrP
downstream targets, ADRP and PPARγ were also up-regulated after ischemia/
reperfusion but only the pulmonary mRNA expression of PPARγ was further
increased by HFD (Fig. 5). These effects were toned down in mice with advanced
age (Fig. 6). A significant increase of pulmonary PTHrP protein expression was
observed after ischemia/reperfusion (Fig. 4). However, no additive effects of HFD
were observed. In contrast, PTH-1 receptor protein expression was significantly
[(Fig._2)TD$FIG]
Fig. 2. Pulmonary mRNA expression of PTHrP, PTH-1 receptor, ADRP, and PPARγ in leptin deficient
mice (Lepob/ob). Data are expressed as means ± S.D. and normalized to wild-type littermates. n = 4
mice each. *, p < 0.05 vs. wild-type littermates.
[(Fig._3)TD$FIG]
Fig. 3. Pulmonary mRNA expression of PTHrP, PTH-1 receptor, ADRP, and PPARγ in thirteen
months old mice that were fed with either normal diet (ND, n = 6), high fat diet (HFD, n = 5). Data are
expressed as means ± S.D. all values p > 0.05 vs. ND.
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[(Fig._4)TD$FIG]
Fig. 4. Pulmonary protein expression of PTHrP and the corresponding PTH-1 receptor in mice. A + B)
Representative western blots from seven months old (A) or thirteen months old (B) mice; HFD = high
fat diet; I/R = ischemia/reperfusion; The original full size blots are given in the supplementary material
as Fig. 4a-PTHrP, Fig. 4a-PTH-1R, Fig. 4a-Actin, Fig. 4b-PTH-1R, Fig. 4b-PTHrP; and Fig. 4b-Actin;
C-F) Mean protein expression of PTHrP and PTH-1 receptor in seven months old mice (C,D) or thirteen
months old mice (E,F). Data are expressed as means ± S.D. and normalized to age-matched mice under
normal diet (always n = 3); *, p < 0.05 vs. normal diet.
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elevated only in the HFD group undergoing ischemia/reperfusion (Fig. 4). Again,
these effects did not maintain at later time points (Fig. 4).
3.3. Effect of high fat diet on pulmonary expression of fibrotic
proteins
The coordinative up-regulation of PTHrP, ADRP, and PPARγ mRNA under HFD
indicates a significant activation of this paracrine pathway by HFD. Pulmonary
function depends on intact lung elasticity that is disturbed by transition of
lipofibroblast into myofibroblasts. This process is attenuated by PTHrP. We
therefore analyzed the pulmonary mRNA expression of pro-fibrotic proteins, such
as TGF-β1, elastin, and fibronectin under conditions that indicated increased
expression of PTHrP namely HFD and ischemia/reperfusion (Fig. 1, Fig. 5). HFD
increased the pulmonary mRNA expression of TGF-β1 and fibronectin (Fig. 7a).
[(Fig._5)TD$FIG]
Fig. 5. Pulmonary mRNA expression of PTHrP, PTH-1 receptor, ADRP, and PPARγ in seven months
old mice that underwent ischemia/reperfusion (I/R) with normal diet (n = 9) or high fat diet (HFD), n =
10). Data are expressed as means ± S.D. and normalized to sham mice with normal diet *, p < 0.05 vs.
sham, #, p < 0.05 vs. I/R.
[(Fig._6)TD$FIG]
Fig. 6. Pulmonary mRNA expression of PTHrP, PTH-1 receptor, ADRP, and PPARγ in thirteen
months old mice that underwent ischemia/reperfusion (I/R) with normal diet (n = 8) or high fat diet
(HFD), n = 6). Data are expressed as means ± S.D. and normalized to sham mice with normal diet. #,
p < 0.05 vs. I/R.
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However, it did not increase the expression of elastin (Fig.7a). Elastin mRNA
slightly increased in HFD mice at a later time point when PTHrP expression was
lower (data not shown). Ischemia/reperfusion and the combination with HFD
produced similar changes in pulmonary expression of TGF-β1 and fibronectin
although large inter individual variation was strong. HFD did not modify this
response and elastin expression was again not different (Fig. 7b).
[(Fig._7)TD$FIG]
Fig. 7. Pulmonary mRNA expression of TGF-β1, elastin and fibronectin in seven months old mice. (A)
Comparison of the effect of nomrla diet (ND) versus high fat diet (HFD) (B) Comparison of the effect
of ischemia/reperfusion (I/R) to sham I/R plus HFD. Data are expressed as means ± S.D. from n = 6–12
mice (see Fig. 1 and 5 for exact numbers) *, p < 0.05 vs. ND of seven months old mice.
Article No~e00182
10 http://dx.doi.org/10.1016/j.heliyon.2016.e00182
2405-8440/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
4. Discussion
This study was aimed to investigate whether modification of plasma leptin levels
as they occur by HFD can modify pulmonary expression of PTHrP. The first
important finding of the present study is that HFD increases the steady state mRNA
expression of PTHrP in the lung in vivo. This effect is most likely linked to
elevated plasma leptin levels because HFD increased plasma leptin levels and
leptin-deficient mice displayed reduced pulmonary PTHrP mRNA expression.
Altered surfactant protein expression with excessive deposition of lipid droplets
has been reported in different models of obesity [6, 9]. PTHrP has been identified
as a main factor regulating surfactant production via a paracrine pathway involving
leptin [23]. The new finding of our study is that extrapulmonary leptin, as it can be
found under HFD, can modify pulmonary PTHrP expression. This increase in
PTHrP mRNA expression by HFD led also to an increased expression of PTH-1
receptor, ADRP and PPARγ. The induction of classical PTHrP-downstream target
genes suggests a physiological relevance of the observed increase in pulmonary
PTHrP mRNA expression. However, a significant increase in PTHrP protein
expression was not found. A possible explanation for the lack of proper protein
expression may be that PTHrP is a paracrince factor. Extracellular PTHrP might
have been washed out during preparation or alternatively be internalized and
rapidly degraded by lipofibroblasts the natural target cells of PTHrP.
PTHrP is one of the main factors in the lung that regulates the epithelial-
mesenchymal paracrine cross-talk. It is a main regulator for the formation of
surfactants [23]. Epithelial cells form a positive feedback to type II alveolar cells
via release of leptin [24]. In this physiological feedback mechanism PTHrP induces
the release of leptin from epithelial cells that than trigger an improved expression
and release of PTHrP [25]. We tested the hypothesis that increasing leptin levels by
HFD can modify the expression of PTHrP as well. We found that HFD increased
plasma leptin levels (as expected) and that pulmonary mRNA expression of PTHrP
was also increased under these conditions. A causal link between plasma leptin
levels and pulmonary expression of PTHrP was also confirmed in leptin deficient
mice that displayed a lower pulmonary expression of PTHrP. Collectively, our
study shows for the first time that plasma leptin levels affect pulmonary expression
of PTHrP a mechanism that had been attributed to the paracrine effects of leptin
derived from epithelial cells before.
The subsequent question is whether the increased pulmonary expression of PTHrP
mRNA indicates an activation of the pulmonary PTHrP system. We were unable to
find a significant increase in PTHrP protein concentration. However, as PTHrP can
easily enter the circulation this does not necessarily tell us anything about an
activation of the pulmonary PTHrP system. Therefore, we addressed this question
by evaluating the expression levels of PTHrP-dependent regulated genes. As
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reported before, PTHrP released from type II alveolar cells acts on adjacent
epithelial cells that express PTHrP receptors. Once PTHrP activates these receptors
in increases the expression of ADRP and PPARγ in these cells [23]. We found
indeed that under conditions of HFD, high plasma leptin levels, and increased
pulmonary expression of PTHrP mRNA the well known down-stream targets of the
pulmonary PTHrP pathway are induced. Both target genes, ADRP and PPARγ
were upregulated.
In general a high activation of the PTHrP-driven epithelial-mesenchymal paracrine
cross-talk is considered as a protective mechanism that allows better oxygenation
of the blood in the lung [22, 23]. Several mechanisms are known by which PTHrP
stabilizes lung function. These are its vasodilating effect that improves perfusion,
its effect on surfactant formation that improves oxygen uptake, and its inhibitory
effect on transdifferentiation of lipofibroblasts into myofibroblasts [8, 23]. We
proved the latter assumption under conditions of HFD-dependent activation of the
PTHrP system by studying the pulmonary expression of elastin. An upregulation of
elastin indicates interstitial pulmonary fibrosis [3, 13, 15]. Our finding that elastin
mRNA expression was not changed under conditions shown to increase pulmonary
PTHrP mRNA expression is in fine agreement with the assumption that activation
of the pulmonary PTHrP system attenuates transactivation of epithelial cells to
myofibroblasts that favours pulmonary fibrosis. We have recently shown that the
pulmonary expression of PTHrP is constitutively repressed by nitric oxide (NO)
[1]. Inhibition of endothelial-derived NO formation significantly increased the
expression of PTHrP, PTH-1 receptor, ADRP, and PPARγ. Under these conditions
an induction of the pulmonary PTHrP system was not associated with increased
surfactant production. A strict coupling between the pulmonary PTHrP system and
surfactant formation in adult rodents has yet to be clarified as there are contrasting
reports in the literature.
A wide variety of events can inhibit the protective role of PTHrP, including
prematurity, barotrauma, oxytrauma, nicotine, and infection [5, 7, 18, 19]. Whether
myocardial infarction also affects pulmonary PTHrP expression and function was
unknown. However, myocardial infarction leads impairs left ventricular filling
with subsequent congestion of the pulmonary venous circulation. Moreover, heart
failure has been linked to endothelial dysfunction in the lung. Therefore, we were
also interested to study the effect of myocardial infarction on the pulmonary
expression of PTHrP. We found an increased expression of PTHrP protein. Former
studies showed that lung structural remodelling after myocardial infarction can be
attenuated by irbesartan, an angiotensin II receptor antagonist [12]. We have
recently shown that captopril, an angiotensin converting enzyme inhibitor, can
attenuate pulmonary induction of PTHrP, but not that of PTH-1 receptor, in a NO-
deficiency model [1]. Collectively the data suggest that an infarct-dependent
activation of the renin-angiotensin-system induces the expression of PTHrP and
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that this contributes to the formerly observed lung structural remodelling. We
found indeed that mice undergoing myocardial infarction displayed induced
pulmonary expression of TGF-β1, fibronectin, and reduced expression of elastin
alongside with increased expression of PTHrP.
The obesity paradox describes a situation in which obese patients tolerate ischemic
events better than non-obese patients. Mice fed with HFD were used here as an
experimental model of obesity. We hypothesized that these mice respond different
to myocardial infarction with respect to the pulmonary PTHrP expression
compared to those mice fed with normal diet. Indeed, pulmonary expression of
PTHrP was high in mice with HFD undergoing myocardial infarction.
Furthermore, PTHrP-1 receptor expression was elevated. However, in the post-
infarct model, HFD caused a rather specific additive effect on the pulmonary
expression of PPARγ that was independent from changes in PTHrP expression
suggesting an PTHrP-independent mechanism on PPARγ expression. Collectively,
these data suggest that HFD does not modify pulmonary expression and activation
of the PTHrP system in the context of myocardial infarction.
Tissue adaption to stress is often reduced or even lost during ageing as shown for
conditioning effects [27]. Therefore, all experiments were analyzed at two different
time points: 6 months and 12 months after starting HFD. Older mice displayed
higher steady state PTHrP mRNA levels und lower elastin levels. As mentioned
above, this can be considered as a PTHrP-dependent repression of the transition of
epithelial cells into myofibroblasts. HFD and ischemia/reperfusion seems to
increase TGF-β1 and fibronectin expression. TGF-β1 is a classical angiotensin II
target and therefore most likely regulated by activation of this pathway. In
accordance to these findings myofibroblasts have been identified in post-infarct
lungs after two weeks [12]. In general, the effects of HFD on the pulmonary
expression of PTHrP and its downstream targets in mice at the age of twelve
months were less pronounced than those on younger mice. The data show that
pulmonary PTHrP mRNA expression can be modified by HFD mainly in young
mice suggesting a desensitization of leptin receptors or activation of compensatory
mechanisms.
In conclusion, the current study shows a remarkable effect of extrapulmonary
leptin on the steady state level of PTHrP mRNA in vivo. HFD increases plasma
levels of leptin that then acts on alveolar type II cells and increases the mRNA
steady state level of PTHrP. Leptin deficient mice (ob mice) have reduced steady
state levels of PTHrP. PTHrP acts in a paracrine way on alveolar interstitial
fibroblasts (lipofibroblasts) and induces the expression of PTH-1 receptors, ADRP
and PPARγ. At least in young mice the effect of HFD on pulmonary expression of
PTHrP may contribute to some of the observations that are generally named the
obesity paradox.
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In recent work, PTHrP had been identified as a main modulator that controls the
alveolar type II epithelial cross-talk. The current study underlines the importance
of leptin in this cell-cell communication. Despite this the current study mainly
confirmed the suggested model how PTHrP acts on epithelial cells. However, we
found specifically under conditions of myocardial infarction an activation of
PPARγ in epithelial cells that was not associated with an activation of PTHrP. This
point requires specific attention in the future, as it is specifically important for
patients with impaired cardiac function.
5. Conclusion
HFD activates the pulmonary PTHrP/leptin cross-talk in healthy mice and this
interaction contributes to lung remodeling. The beneficial effect of HFD on this
pathway drops during ageing.
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